W. J. Hudson

Dichotomous effects of exposure to bivalirudin in patients undergoing percutaneous coronary intervention on protease-activated receptor-mediated platelet activation

H. Hamm, Qingxia Chen, M. Holinstat, 2013, Journal of Thrombosis and Thrombolysis.

Racial Differences in Resistance to P2Y12 Receptor Antagonists in Type 2 Diabetic Subjects

F. Harrell, H. Hamm, M. Holinstat, 2014, The Journal of Pharmacology and Experimental Therapeutics.

Irreversible Platelet Activation Requires Protease-Activated Receptor 1-Mediated Signaling to Phosphatidylinositol Phosphates

H. Hamm, H. Brown, S. Milne, 2009, Molecular Pharmacology.